Advertisement
Table 3 Sensitivity analyses by random versus fixed effects for serious infection risk by comparison of significant estimates between random and fixed effects models
| Comparison | Random effects model | Fixed effects model |
|---|---|---|
| Odds ratio (95 % CrI) | Odds ratio (95 % CrI) | |
| TAC vs. glucocorticoids | 0.33 (0.12–0.88) | 0.33 (0.13–0.82) |
| TAC vs. CYC | 0.37 (0.15–0.87) | 0.37 (0.16–0.82) |
| TAC vs. MMF | 0.40 (0.18–0.81) | 0.40 (0.20–0.78) |
| TAC vs. AZA | 0.32 (0.12–0.81) | 0.32 (0.13–0.77) |
| CYC LD vs. TAC | 4.84 (1.48–17.64) | 4.50 (1.43–14.50) |
| HD glucocorticoids vs. TAC | 12.83 (1.53–119.90) | 12.22 (1.58–105.70) |
| CYC HD vs. TAC | 6.60 (2.25–20.50) | 6.52 (2.38–18.95) |
| MMF-AZA vs. CYC LD | 0.09 (0.01–0.76) | 0.09 (0.01–0.74) |
| MMF-AZA vs. HD glucocorticoids | 0.03 (0.00–0.56) | 0.21 (0.02–1.79) |
| MMF-AZA vs. CYC HD | 0.07 (0.01–0.54) | 0.07 (0.01–0.47) |
| MMF-AZA vs. CYC-AZA | 0.14 (0.02–0.71) | 0.14 (0.02–0.65) |
| Residual deviance | 72.49 | 74.9 |
| Number of unconstrained data points | 71 | 71 |
| Deviance information criteria | 325.646 | 325.51 |
